EUVIMEDEUVIMED entdecken
Crossref

Disentangling gray matter atrophy and its neurotransmitter architecture in drug-naïve Parkinson’s disease: an atlas-based correlation analysis

Huize Pang, Xiaolu Li, Ziyang Yu, Hongmei Yu, Shuting Bu, Juzhou Wang, Mengwan Zhao, Yu Liu, Yueluan Jiang, Guoguang Fan iD

Cerebral Cortex · 03.10.2024 · 34 (10)

DOI: 10.1093/cercor/bhae420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cerebral Cortex, online erschienen am 17.10.2024. Verfasst von Huize Pang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, Liaoning Province, 1100…. Hauptthemen laut MEDLINE: Gray Matter, Parkinson Disease, Atrophy, Magnetic Resonance Imaging. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease is characterized by multiple neurotransmitter systems beyond the traditional dopaminergic pathway, yet their influence on volumetric alterations is not well comprehended. We included 72 de novo, drug-naïve Parkinson’s disease patients and 61 healthy controls. Voxel-wise gray matter volume was evaluated between Parkinson’s disease and healthy controls, as well as among Parkinson’s disease subgroups categorized by clinical manifestations. The Juspace toolbox was utilized to explore the spatial relationship between gray matter atrophy and neurotransmitter distribution. Parkinson’s disease patients exhibited widespread GM atrophy in the cerebral and cerebellar regions, with spatial correlations with various neurotransmitter receptors (FDR-P < 0.05). Cognitively impaired Parkinson’s disease patients showed gray matter atrophy in the left middle temporal atrophy, which is associated with serotoninergic, dopaminergic, cholinergic, and glutamatergic receptors (FDR-P < 0.05). Postural and gait disorder patients showed atrophy in the right precuneus, which is correlated with serotoninergic, dopaminergic, gamma-aminobutyric acid, and opioid receptors (FDR-P < 0.05). Patients with anxiety showed atrophy in the right superior orbital frontal region; those with depression showed atrophy in the left lingual and right inferior occipital regions. Both conditions were linked to serotoninergic and dopaminergic receptors (FDR-P < 0.05). Parkinson’s disease patients exhibited regional gray matter atrophy with a significant distribution of specific neurotransmitters, which might provide insights into the underlying pathophysiology of clinical manifestations and develop targeted intervention strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gray MatterParkinson DiseaseAtrophyMagnetic Resonance ImagingNeurotransmitter AgentsHumansFemaleMaleMiddle AgedAgedBrain

Stichwörter der Autor:innen

Parkinson’s diseasemagnetic resonance imagingneurotransmitterpositron emission tomographyvoxel-based morphometry

Substanzen

Neurotransmitter Agents

Autor:innen und Institutionen

  • Department of Radiology, The First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, Liaoning Province, 110001, China.
  • Key Laboratory for Biomedical Engineering of Ministry of Education, Department of Biomedical Engineering, College of Biomedical Engineering & Instrument Science, Zhejiang University, 38 Zheda Road, Xihu District, Hangzh…
  • Department of Neurology, The First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, Liaoning Province, 110001, China.
  • MR Research Collaboration, Siemens Healthineers, 7 Wangjing Zhonghuan South Road, Chaoyang District, Beijing, 100102, China.

ORCID-Profile: Guoguang Fan

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Pang, H., Li, X., Yu, Z., Yu, H., Bu, S., Wang, J., Zhao, M., Liu, Y., Jiang, Y., & Fan, G. (2024). Disentangling gray matter atrophy and its neurotransmitter architecture in drug-naïve Parkinson’s disease: an atlas-based correlation analysis. Cerebral Cortex, 34(10). https://doi.org/10.1093/cercor/bhae420

Vancouver

Pang H, Li X, Yu Z, Yu H, Bu S, Wang J, et al. Disentangling gray matter atrophy and its neurotransmitter architecture in drug-naïve Parkinson’s disease: an atlas-based correlation analysis. Cerebral Cortex. 2024;34(10). doi:10.1093/cercor/bhae420

BibTeX
@article{Pang2024,
  author = {Pang, Huize and Li, Xiaolu and Yu, Ziyang and Yu, Hongmei and Bu, Shuting and Wang, Juzhou and Zhao, Mengwan and Liu, Yu and Jiang, Yueluan and Fan, Guoguang},
  title = {Disentangling gray matter atrophy and its neurotransmitter architecture in drug-naïve Parkinson’s disease: an atlas-based correlation analysis},
  journal = {Cerebral Cortex},
  year = {2024},
  volume = {34},
  number = {10},
  doi = {10.1093/cercor/bhae420}
}
Kostenlos starten →